BioLineRx to Deliver Oral Presentation at ESMO
Dec 13, 2019
Abstract title: A Multi-Center Phase 2a Trial to Assess the Safety and Efficacy of BL-8040 (a CXCR4 inhibitor) in Combination with Pembrolizumab and Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma (PDAC)
Presentation No.: 91O
Lecture time: 11:00-11:30am CET
Location: Room C
Supporting Materials
Click here for presentation 1.2 MB
Location
Geneva, Switzerland